OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
It is essential to ensure the safety profiles of potential COVID-19 therapies are supported by robust data so that healthcare providers and physicians can make appropriate, evidence-based decisions, writes Dr. Andrew Rut.